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BY-NC-ND license (http://creativecomBackground/Purpose: The Stagnara wake-up test assesses neurological deficits during scoliosis
surgery, and response surface interaction models for opioids and inhaled agents predicts anes-
thetic drug effects. We hypothesized that there is an optimal desfluraneefentanyl dosing
regimen that can provide a faster and more predictable wake-up time, while also ensuring
adequate analgesia during wake-up testing.
Methods: Twenty-three American Society of Anesthesiologists Class IeII scoliosis patients who
received desfluraneefentanyl anesthetic regimens were enrolled in this posthoc study, and
their intraoperative drug administration data were collected retrospectively. Desflurane and
fentanyl effect site concentrations were calculated using pharmacokinetic models, and con-
verted to equivalent remifentanilesevoflurane concentrations.
Results: Results were fitted into Greco models for predicting the probability of an Observers
Assessment of Alertness/Sedation score of <2. At time of wake-up, the models correctly pre-
dicted the probability that patients would respond to voice prompts and prodding was approx-
imately 50%. The probability of pain intensity was distributed between 50% and 95%, indicating
a low degree of pain at emergence. When comparing subgroups defined by calculated effect-
site fentanyl concentrations, the wake-up time in the intermediate concentration group was
significantly shorter than that in the high concentration group (p Z 0.024).ave no conflicts of interest relevant to this article.
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tanyl effect-site concentrations (1e2 ng/mL) at time of wake-up were associated with good
balance between rapid emergence and adequate analgesia. Furthermore, we believe that
generalizing response surface models to a variety of inhalation agent-opioid combinations us-
ing simple relative potency relationships is possible and practical.
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The Stagnara wake-up test has been used to assess neuro-
logical deficits during scoliosis surgery since 1973.1 In this
test, the patient is briefly allowed to emerge from anes-
thesia to participate in a neurological assessment, while
still remaining adequately sedated and receiving sufficient
analgesia to tolerate pain from the incision and endotra-
cheal tube.2 Although somatosensory-evoked potentials and
motor-evoked potentials have replaced wake-up testing as
the standard neurological testing, the wake-up test is still
used by many surgeons.3e8 It can be challenging for the
anesthesiologist to achieve both rapid wake-up onset and
adequate analgesia during scoliosis surgery. To our knowl-
edge, there is still no practice guideline that informs an-
esthesiologists of which anesthetic combination is optimal
for intraoperative wake-up testing.
Response surface interaction models investigate drug
interactions. It can be used to predict clinical outcomes
such as loss of response to verbal command, reduced
perception, loss of response to noxious stimuli, the
occurrence of unwanted side effects, or predicting certain
physiology-based monitor values.3 Response surface
interaction models for opioids and inhaled agents have
been used to predict anesthetic drug effects such as
analgesia, sedation, and loss of responsiveness.4e6 Potency
between different medications can be converted and the
converted doses can be compared just like different opi-
oids can be converted into morphine equivalent doses for
comparison.6 We have established a sevo-
fluraneeremifentanil interaction model based on obser-
vations in volunteers and found that an Observers
Assessment of Alertness/Sedation (OAA/S) score of <2, in
which the patient responds only after moderate prodding
or shaking, is a good surrogate model for wake-up testing.7
In our previous work, a sevofluraneeremifentanil interac-
tion model was adapted to test desfluraneefentanyl, and
shown to accurately predict patients’ responses during
wake-up testing. Based on these results, we hypothesized
that there is an ideal desfluraneefentanyl regimen that
enables a faster wake-up time (<10 minutes), more ac-
curate prediction of waking, and adequate analgesia,
thereby allowing patients to complete a neurologic
assessment.
The aim of the present study was to identify an opti-
mized desfluraneefentanyl dosing regimen for wake-up
testing based on actual dosing regimens, and to model
predictions of responsiveness and analgesia.ng W-N, et al., A desflurane and fe
mergence from anesthesia, JournMaterials and methods
Patients
Previously collected data were used in the present study.
The parameters analyzed included anesthesia, wake-up
procedure, and data derived from the aforementioned
pharmacokinetic simulation and response surface models.7
The Taipei Veterans General Hospital Review Board (Taipei,
Taiwan) approved the study. The Institutional Review Board
agreed that no written informed consent from the partici-
pants was needed while all patient records/information
was anonymized and deidentified prior to analysis. Twenty-
three American Society of Anesthesiologists (ASA) Class IeII
patients that underwent surgical scoliosis correction under
general anesthesia with desfluraneefentanyl between 2005
and 2011 were retrospectively enrolled, and their medical
charts were reviewed.
Anesthesia
A standardized anesthesia protocol was followed,
comprising induction with propofol (2 mg/kg), fentanyl
(5 mg/kg), and cisatracurium or rocuronium to facilitate
endotracheal intubation. Maintenance was conducted with
desflurane and bolus doses of fentanyl to keep blood
pressure and heart rate within 20% of baseline, and inter-
mittent bolus injections of cisatracurium were given to
maintain one twitch after train-of-four stimuli conditions.
The tidal volume was set at 8 mL/kg, and end-tidal carbon
dioxide was maintained between 32 mmHg and 36 mmHg by
adjusting the tidal volume.
Wake-up testing
The timeline of events are presented in Figure 1. Admin-
istration of cisatracurium and fentanyl was interrupted 30
minutes before the anticipated initiation of the wake-up
test (T0). The wake-up test was initiated upon the sur-
geon’s request, and the desflurane vaporizer was turned off
(T1). Fresh gas flow was increased to 4 L/min.
During the wake-up test, patients were addressed loudly
by their first name, and asked, “can you move your fingers
and toes?” If they did not respond within 2 seconds, the
procedure was repeated at 10-second intervals until they
did respond. Wake-up time was defined as the duration of
time between the desflurane vaporizer being turned offntanyl dosing regimen for wake-up testing during scoliosis surgery:
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Figure 1 Timeline of events. T0: 30 minutes before antici-
pated initiation of wake-up, as set by the surgeon, cis-
atracurium and fentanyl were discontinued; T1: initiation of
wake-up. Desflurane vaporizer was turned off. T2: actual time
of wake-up. Patients moved their fingers and toes. T3: resume
desflurane and fentanyl, end of wake-up testing.







C50 remifentanil (ng/mL) 23.10 1.27
C50 sevoflurane (vol%) 0.78 0.83
Interaction (a) 26.68 0.91
Steepness (n) 2.46 2.71
Model parameters were fit to a Greco model structure from
responses recorded in volunteers.
C50Z effect-site concentrations that produced 50% of the
maximal effect when remifentanil or sevoflurane was adminis-
tered; OAA/SZObserver’s Assessment of Alertness/Sedation;
PSIZ pounds per square inch; a and nZmodel parameters
representing the steepness of the dose-response relationship
and the interaction between sevoflurane and remifentanil.7
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toes (T2). A “moderately painful stimulus” [defined as 30
pounds per square inch (PSI) or 207 pascals of anterior tibial
pressure]5,6 was also applied every 15 seconds. After
neurological testing, desflurane and fentanyl resumed and
that concludes the wake-up testing (T3). We recorded the
time each drug was administered, surgical events, end-tidal
desflurane concentrations, and patient responses to surgi-
cal stimuli, pain stimuli, and verbal commands.Modeling of effect-site concentrations
A response surface model of remifentanil and sevoflurane,
which was established previously in a volunteer study, was
used for comparison.3,5 The concentrations of fentanyl and
desflurane need to be converted to remifentanyl and sev-
oflurane concentrations to fit this model. We used fentanyl
pharmacokinetic models8,9 to calculate fentanyl effect-site
concentrations throughout the procedure, and these values
were converted to equivalent remifentanil effect-site con-
centrations based on a relative potency of remifentanil to
fentanyl of 1:1.2.10e12 A desflurane pharmacokinetic model
was used to calculate brain tissue concentrations.13,14
Desflurane brain tissue concentrations were converted to
equivalent sevoflurane effect-site concentrations based on
a potency equivalence of sevoflurane to desflurane of 3.3:1.
The response surface models for predicting the probability
of an OAA/S score of <2,15 which the patient responds only
after moderate prodding or shaking, at given remifentanil
and sevoflurane concentrations were established based
on data collected from volunteers in previously reported
studies.3,5 Table 1 shows the parameters estimated by
the two models, which were based on a Greco model
structure.16
The probability that the patient would not respond to a
30-PSI anterior tibia stimulus was calculated via a previ-
ously established model.4Evaluation of response surface model predictions
Model predictions of the likelihood of an OAA/S score of <2
and no response to 30 PSI of anterior tibial pressure ranging
from 0% to 100% were calculated every 10 seconds, begin-
ning with termination of the anesthetic and ending 10 mi-
nutes after each patient woke up. Model predictions were
compared with clinical observations and graphical analyses.Please cite this article in press as: Teng W-N, et al., A desflurane and fe
Implications for the time-course of emergence from anesthesia, Journ
10.1016/j.jfma.2016.10.001Graphical analysis
Predictions from each model for OAA/S were compared
graphically. A plot of the desfluraneefentanyl concentra-
tions at the time of emergence was superimposed onto a
topographical representation of the response surface
model predictions for an OAA/S score of <2 and no
response to 30 PSI of anterior tibial pressure (pressure
algometry). The topographical plot included the 5%, 50%,
and 95% isoboles. We defined isoboles as the set of des-
fluraneefentanyl concentration pairs that produced the
same probabilities of effect.
The fentanyl effect-site concentrations were calculated
for each patient at the beginning of wake-up testing.
According to these calculations, we divided the 23
patients into three subgroups: L (low initial fentanyl group,
< 1 ng/mL), I (intermediate initial fentanyl group,  1 ng/
mL and < 2 ng/mL), and H (high initial fentanyl group,
 2 ng/mL). The mean durations of the time from the
beginning of wake-up testing (T1) until the observed wake-
up time (T2) in each of the three groups were compared via
a nonparametric KruskaleWallis test.17 The ManneWhitney
U test18 was also employed to analyze the three sample
pairs for significant differences. Boxplots and KaplaneMe-
ier analyses were used to perform graphical comparisons.
All plots were constructed using Sigmaplot 12 (Systat Sof-
teware, Inc., San Jose, CA, USA) and Matlab R2013b (The
Mathworks Inc., Natick, MA, USA).
Results
Table 2 lists the demographics and surgical times for the 23
patients in the study. Three surgeons and 11 anesthesiolo-
gists in total participated in the procedures analyzed in this
study. After recovery, none of the patients reported
recalling any portion of the procedure except for events
that occurred during the wake-up test, and none recalled
pain during the test.
The mean duration of time from desflurane being turned
off (T1) to the patient waking up (T2) was 10.3 4.7 mi-
nutes. Figure 2 shows the three new response surface
model’s predictions of the probabilities that each patientntanyl dosing regimen for wake-up testing during scoliosis surgery:
al of the Formosan Medical Association (2016), http://dx.doi.org/
Table 2 Patient demographic data and surgery statistics.
Groups L (nZ 4) I (nZ 6) H (nZ 13) p
Age (y) 14.8 1.5 16.0 3.2 16.2 3.2 0.601
Sex, n (male/female) 1/3 3/3 4/9 0.646
ASA, n (I/II) 2/2 3/3 8/5 0.858
Weight (kg) 52.5 6.0 52.3 8.5 50.5 9.9 0.956
Height (cm) 162.9 6.2 164.6 9.4 160.5 5.2 0.535
BMI (kg/m2) 19.8 2.5 19.2 1.0 19.7 4.1 0.905
Intubation to T3 (min) 261.3 44.8 236.0 41.7 275.0 61.2 0.183
T1 to T2 (min) 7.1 5.6 7.9 3.7 12.3 4.1 0.046
T3 to end of anesthesia (min) 157.5 18.5 165.0 34.8 153.3 45.5 0.517
Data are represented as mean standard deviation.
ASAZ American Society of Anesthesiologists; BMIZ body mass index; HZ high initial fentanyl group; IZ intermediate initial fentanyl
group; Intubation to T3Z duration of time from endotracheal intubation to end of wake-up testing (T3); LZ low initial fentanyl group;
T1eT2Z duration of time from desflurane being turned off (T1) to the patient waking up (T2); T3 to end of anesthesiaZ duration of time
from end of wake-up testing (T3) to end of anesthesia.
Figure 2 Drug effect-site concentrations from the beginning
of wake-up testing to actual emergence. Drug effect-site
concentration pairs changing tracks from initiation of wake-
up testing (T1) to actual emergence (T2) presented as the %
volume of the desfluraneefentanyl effect-site concentrations
for each of the 23 patients. The concentration pairs are shown
with three probabilities from the Observers Assessment of
Alertness/Sedation score <2 response surface model. The
dash-dot, solid, and dotted lines represent the 95%, 50%, and
5% model-predicted probabilities, respectively. Black, red, and
green lines represent the median, high, and low initial fentanyl
effect-site group pairs, respectively. All track line ticks
represent 1 minute. CEZ effect site concentration; Group
HZ high initial fentanyl group; Group IZ intermediate initial
fentanyl group; Group LZ low initial fentanyl group.
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10.1016/j.jfma.2016.10.001would respond to a loud voice command and moderate
prodding 20 minutes before and 10 minutes after the time
the patient actually moved their fingers and toes during the
wake-up test. At the time the patients responded, the
response surface model’s prediction of the probability of an
OAA/S score of <2 had a mean of 56.2%  26.7%. Figure 2
also shows the reductions in desflurane and fentanylFigure 3 Calculated drug effect-site concentration pairs at
the time of wake-up. Drug effect-site concentration pairs at
the time of wake-up are presented as volume% for the des-
flurane and fentanyl effect-site concentrations for each of the
23 patients. The concentration pairs are shown in conjunction
with three probabilities from the pressure algometry (proba-
bility of no response to 30 PSI of anterior tibial pressure)
response surface model previously developed in a laboratory
study of volunteers.4,5 Black dots represent the median initial
fentanyl effect-site group pairs, red stars indicate the high
initial fentanyl effect-site group pairs, and green dots repre-
sent the low initial fentanyl effect-site group pairs. CEZ ef-
fect site concentration; Group HZ high initial fentanyl group;
Group IZ intermediate initial fentanyl group; Group LZ low
initial fentanyl group.
ntanyl dosing regimen for wake-up testing during scoliosis surgery:
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Figure 4 Wake-up time analysis. The KaplaneMeier curves
for the three initial fentanyl effect-site concentration groups.
The wake-up time in Group H was significantly longer than that
in Group I (pZ 0.024) but no statistical significance were found
between Groups H and L or between I and L. Group HZ high
initial fentanyl group; Group IZ intermediate initial fentanyl
group; Group LZ low initial fentanyl group.
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three black curves show the concentrations where there
were 5%, 50%, and 95% probabilities of an OAA/S score <2.
The final concentrations (those predicted for when the
patient moved their fingers and toes) were approximately
equally distributed, and the probability that patients would
respond to voice prompts and prodding were approximately
50%; 16 patients had concentrations >50% and seven had
concentrations <50%. Desflurane concentrations fell more
rapidly than fentanyl concentrations.
Figure 3 shows the desflurane and fentanyl effect-site
concentration pairs for each patient at the time of emer-
gence plotted in conjunction with isoboles of the previously
developed response surface model for 30 PSI of anterior
tibial pressure. The effect-site concentration pairs for
desflurane and fentanyl were mainly distributed between
model predictions of 50% and 95%, with only two patients,
both in group L, that had concentrations less than 50%.
The patients’ mean wake-up durations (from T1 to T2) in
groups L (nZ 4), I (nZ 6), and H (nZ 13) were 7.13 5.60
minutes, 7.89 3.67 minutes, and 12.30 4.10 minutes,
respectively. There was a significant wake-up time differ-
ence between the three groups detected with a Krus-
kaleWallis test (pZ 0.046). A ManneWhitney U test for
Group I versus Group H also revealed a significant differ-
ence (pZ 0.048), whereas the other two comparisons (L vs.
I and L vs. H) were not statistically significant (pZ 0.522
and 0.054, respectively). The KaplaneMeier curves for the
three initial fentanyl effect-site concentration groups are
shown in Figure 4.Discussion
On average, patients moved their fingers and toes within 3
minutes of the 50% model prediction probability for
regaining consciousness. Before beginning wake-up testing,
the model predicted >95% probabilities of the patient
being unconscious, which was consistent with intra-
operative observations. Once the anesthetic was termi-
nated at T1, the model predictions rapidly decreased, and
patients emerged from anesthesia over a wide range of
model predictions. Although more than 79% of patients
woke up within 5 minutes of the 50% model prediction, the
overall distribution of the time differences was large
(Figure. 2). Notably, among the five longest time differ-
ences presented in Figure 3, ranging from 5.5 minutes to
10.3 minutes, three of them were in the low initial fentanyl
effect-site concentrations group (Group L), which only
contained four patients. The mean initial of fentanyl
effect-site concentration in group L was 0.375 0.063 ng/
mL, whereas the remaining 19 patients had a mean initial
fentanyl concentration of 2.443 0.680 ng/mL. For pa-
tients in this group, response surface models used to pre-
dict wake-up time may need to be adjusted to improve
model predictions.
The model predictions for no response to pain at wake-up
time were generally consistent with intraoperative obser-
vations (Figure 3). For the majority of patients, the model
predicted that the probability of no response to 30 PSI of
tibial pressure was >50%. However, the analgesic effects
were difficult to evaluate because the patients werePlease cite this article in press as: Teng W-N, et al., A desflurane and fe
Implications for the time-course of emergence from anesthesia, Journ
10.1016/j.jfma.2016.10.001intubated, and none of them recalled the wake-up test after
they woke up in the postanesthesia care unit. Only two pa-
tients in the low initial fentanyl effect-site concentration
group (Group L) had model predictions of no response to
tibial pressure of <50%. These individuals might have had a
high risk of poor analgesia quality, which can cause severe
complications such as irritability and falling from the table
during spine surgery. Based on the results of the present
study, we cannot be sure that a tibial pressure of 30 PSI is an
appropriate surrogate indicator of the level of pain during
the wake-up period in scoliosis correction surgery. However,
the results were difficult to interpret, as we only evaluated a
small sample of patients who underwent a range of extents
of scoliosis corrective surgery, which are associated with
different degrees of pain.
Although the bispectral index score and A-line autore-
gressive index are widely used in clinical anesthesia, they
cannot predict the results of the wake-up test well, espe-
cially during opioid-dominant anesthesia.19,20 Grottke and
coworkers21 concluded that desflurane-based anesthesia
was most likely to achieve this predictive goal. Desflurane
allowed rapid and predictable awakening during intra-
operative wake-up testing.22
The longer wake-up time in the high initial fentanyl
group in comparison to the normal and low fentanyl groups
was most likely due to fentanyl’s long half-life. Fentanyl is
considerably more fat-soluble than desflurane and there-
fore has a less predictable half-life after prolonged
administration.23 This likely led to accumulation and
prolonged emergence times, whereas the effects of des-
flurane wore off more rapidly due to its faster
pharmacokinetics.20,24e26 These results are shown in
Figure 2. The changing track of desfluraneefentanyl effect-
site concentration pairs was almost vertical during the
wake-up process. In the 10e20-minute scale, the fentanyl
effect-site concentrations decreased little compared withntanyl dosing regimen for wake-up testing during scoliosis surgery:
al of the Formosan Medical Association (2016), http://dx.doi.org/
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centration had a greater effect on the total wake-up time.
We attempted to determine which of the three different
initial fentanyl effect-site concentration groups had a
shorter wake-up duration with a low risk of poor analgesia
quality. Wake-up durations were longer for patients in
Group H (> 2 ng/mL) than those in Group I ( 1 ng/mL, <
2 ng/mL). Fentanyl was thus the limiting drug in defining
the time to wake-up; the inhaled desflurane duration had
little or even no influence. Using the model for no response
to tibial pressure, Group L (< 1 ng/mL) patients might have
had a relatively high risk of inadequate analgesia. Main-
taining steady-state effect-site fentanyl concentrations
between 1 ng/mL and 2 ng/mL might be recommended for
wake-up testing, as it provides the best balance of rapid
arousal and adequate analgesia.
Remifentanil is an opioid with an ultra-short half-life and
a super rapid clearance rate,27 and it is currently recom-
mended in the literature for wake-up testing during scoli-
osis surgery.21,28 However, the drug itself may impair
postoperative sleep.2,28 Remifentanil is also a relatively
expensive drug and it is not available in some parts of the
world. Grottke and coworkers21 concluded that an anes-
thetic regimen with desflurane and remifentanil facilitated
more rapid emergence during spinal surgery, and permitted
immediate neurological examination (a mean wake-up time
of 6.2 1.0 minutes). In our study, the intermediate fen-
tanyl effect-site concentration (Group I) exhibited a mean
wake up time of 7.9 3.7 minutes, which was only 1e2
minutes slower than the desfluraneeremifentanil group in
Grottke et al’s study.21 However, Rehberg and colleagues2
found that patients undergoing scoliosis surgery with
intraoperative wake-up testing using remifentanil had
impaired sleep quality that lasted up to 6-months post-
operation. Our results suggest that the response surface
model could help anesthesiologists administer a des-
fluraneefentanyl regimen that achieves a similar wake-up
time to desfluraneeremifentanil and avoids the potential
long-term side effects of remifentanil.
In addition to the need for an adequate anesthetic
regimen to permit immediate neurological examination, it
is crucial to ensure intraoperative hemodynamic stability.
Hypotensive anesthesia is widely used in spinal surgery to
reduce blood loss and to facilitate attainment of a blood-
less wound.29 Nitroglycerin was infused in all patients in
this study to ensure hemodynamic stability. This may be
one reason for the high variability in initial fentanyl effect-
site concentrations. However, it also provided an opportu-
nity to identify the best anesthetic combinations for wake-
up testing.
There are several limitations that may have affected our
analysis. Firstly, there were only four and six patients in
Groups L and I, respectively. These group sizes may be
insufficient for statistical analyses given the observed
patient-to-patient variability. A second limitation is that
several studies have reported that the minimum alveolar
concentration (MAC) and MAC-awake values over a range of
patient ages.30 Drug interactions such as reduction of MAC
of desflurane with fentanyl10,31 may also affect our results.
The MAC for sevoflurane ranges from 1.58e2.05% in pa-
tients aged between 30 years and 50 years,32e38 and for
desflurane the range is 6.00e7.25%,10,11,39e42 resulting in aPlease cite this article in press as: Teng W-N, et al., A desflurane and fe
Implications for the time-course of emergence from anesthesia, Journ
10.1016/j.jfma.2016.10.001sevoflurane/desflurane potency range of 1.3e1.8. MAC-
awake ranges from 0.61e0.70% for sevoflurane,36,38,43 and
2.42e2.60% for desflurane,44,45 resulting in a potency range
of 2.9e4.6. For the purposes of this analysis, we selected a
potency ratio of 3.3, which overlapped the MAC and MAC-
awake potency ranges. A different choice may have yiel-
ded different results. A third limitation is that the patient
responses to pain were derived from the 30-PSI tibia pres-
sure model, which may or may not fully represent intra-
operative pain intensity. In the aforementioned volunteer
study, OAA/S assessments, and the 30-PSI tibia pressure
model were performed in the absence of ongoing pain and
without an endotracheal tube in place. We used this model
to predict the results of wake-up testing from general
anesthesia in intubated patients with mild to moderate
surgical pain. However, no volunteer study can fully
emulate the complexities of the clinical environment. The
differences between the volunteer study from which the
models were based and the clinical environment in which
the models were applied likely affected the predictive
ability of the models to some degree. Furthermore, residual
propofol and midazolam, which were given as an induction
agent and premedication, respectively, may have had a
minor influence on the study, although it seems likely that
the concentrations would be too low to confound the model
predictions.5 Nitraglycerin, which was used in several pa-
tients to control blood pressure and minimize surgical site
bleeding, may mask the pain response in patients.
In summary, rapid emergence and immediate neurolog-
ical evaluation are highly desirable during wake-up tests.
This clinical study provides evidence that des-
fluraneefentanyl-based anesthesia can achieve this goal.
The steady-state effect-site concentration of fentanyl
before the wake-up test of between 1 ng/mL and 2 ng/mL
allowed an appropriate balance between rapid emergence
and adequate analgesia. These encouraging results indicate
that response surface models with simple relative potency
relationships can be used for a variety of inhalation agent-
opioid combinations.References
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